Low Prognostic Nutritional Index and high systemic oxidative stress score independently associated with poorer prognosis

No difference in mortality risk seen for GLP-1 RA and SGLT2i users; significantly lower risk seen for GLP-1 RA versus DPP4i users

Increase in primary end point of death, heart failure hospitalization seen in association with baseline AF for patients undergoing M-TEER

Both guselkumab regimens superior to placebo

By Denise Mann HealthDay ReporterTHURSDAY, July 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as “subpotent” active ingredients.The recall of more than 160,000 bottles of levothyroxine sodium, which went into effect …

By Denise Mann HealthDay ReporterTHURSDAY, July 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic hand eczema (CHE).CHE is a common condition marked by redness, itching and cracking on the hands and wrists.Anzupgo (delgocitinib cream) is approved …

During same time period, birth rate increased 1 percent, reaching 3,628,934 births

Women who started dialysis during pregnancy more often had adverse maternal and fetal outcomes

After propensity score matching, overall survival, PFS, nonrelapse mortality did not significantly differ for those 65 years and older versus younger than 65 years

GLP-1 receptor agonist use linked to lower risk for overall dementia, Alzheimer disease, nonvascular dementia compared with metformin